2021
Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application
Buono FD, Lalloo C, Larkin K, Zempsky WT, Ball S, Grau LE, Pham Q, Stinson J. Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application. Contemporary Clinical Trials Communications 2021, 25: 100883. PMID: 35036627, PMCID: PMC8743203, DOI: 10.1016/j.conctc.2021.100883.Peer-Reviewed Original ResearchNeurofibromatosis type 1Pain symptomsNF1 populationType 1Chronic pain symptomsSelf-management treatmentPersistent painTreatment satisfactionTreatment optionsControl studySix weeksPainPsychometric evaluationContingency managementInitial effectivenessGenetic disordersThird groupSymptomsAdultsTreatmentPopulationDifferent populationsGroupParticipants' experiencesGreater reach
2018
Culturally Adapted, Web-Based Cognitive Behavioral Therapy for Spanish-Speaking Individuals With Substance Use Disorders: A Randomized Clinical Trial.
Paris M, Silva M, Añez-Nava L, Jaramillo Y, Kiluk BD, Gordon MA, Nich C, Frankforter T, Devore K, Ball SA, Carroll KM. Culturally Adapted, Web-Based Cognitive Behavioral Therapy for Spanish-Speaking Individuals With Substance Use Disorders: A Randomized Clinical Trial. American Journal Of Public Health 2018, 108: 1535-1542. PMID: 30252519, PMCID: PMC6187780, DOI: 10.2105/ajph.2018.304571.Peer-Reviewed Original ResearchConceptsSubstance use disordersCognitive-behavioral treatmentUse disordersSubstance use outcomesClinical trialsWeb-based cognitive behavioral therapyCurrent substance use disorderUse outcomesRandomized clinical trialsStandard outpatient treatmentEvidence-based treatmentsCognitive behavioral therapyPrimary outcomeStandard treatmentOutpatient treatmentStandard outpatientTreatment completionHealth disparitiesBehavioral therapyBehavioral treatmentAddiction treatmentTreatment-seeking individualsGreater reductionTreatmentDisordersAn investigation of an open‐access model for scaling up methadone maintenance treatment
Madden LM, Farnum SO, Eggert KF, Quanbeck AR, Freeman RM, Ball SA, Schottenfeld RS, Shi JM, Savage ME, Barry DT. An investigation of an open‐access model for scaling up methadone maintenance treatment. Addiction 2018, 113: 1450-1458. PMID: 29453891, DOI: 10.1111/add.14198.Peer-Reviewed Original ResearchConceptsNon-medical opioid useOpioid use disorderMethadone maintenance treatmentOpioid useMaintenance treatmentTreatment accessUse disordersTreatment modelMethadone maintenance treatment centersMaintenance treatment centersDeleterious effectsMethadone treatmentPatient mortalityTreatment optionsTreatment outcomesTreatment centersProspective patientsRate of retentionPatient censusRapid enrollmentAddiction treatmentApparent deleterious effectsTreatmentMortalityProgrammatic outcomes
2013
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance
Moore BA, Fazzino T, Barry DT, Fiellin DA, Cutter CJ, Schottenfeld RS, Ball SA. The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance. Journal Of Substance Use And Addiction Treatment 2013, 45: 63-69. PMID: 23375114, PMCID: PMC3642223, DOI: 10.1016/j.jsat.2012.12.011.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAdultAutomationCocaine-Related DisordersFeasibility StudiesFemaleHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePatient SatisfactionPilot ProjectsSubstance Abuse DetectionTelephoneTherapy, Computer-AssistedConceptsMethadone maintenanceLarge clinical trialsTelephone-based treatmentCurrent pilot studyPatient satisfactionClinical trialsPatient utilizationComputer-based treatmentPilot trialInitial efficacyInteractive voice response systemDrug usePatientsScreen outcomesVoice response systemPilot studyIllicit drugsTreatmentDaily useTrialsEfficacyOpioidsAbstinenceRecovery lineCocaine
2011
Personality Disorders and Retention in a Therapeutic Community for Substance Dependence
Samuel DB, LaPaglia DM, Maccarelli LM, Moore BA, Ball SA. Personality Disorders and Retention in a Therapeutic Community for Substance Dependence. American Journal On Addictions 2011, 20: 555-562. PMID: 21999502, PMCID: PMC3856923, DOI: 10.1111/j.1521-0391.2011.00174.x.Peer-Reviewed Original ResearchConceptsAntisocial personality disorderProgram retentionEarly attritionPersonality disorderSubstance use disordersTherapeutic community treatmentPersonality disorder diagnosisSuccessful treatmentTreatment completionRisk individualsTreatment retentionUse disordersCommunity treatmentSurvival analysisPromising interventionSubstance dependenceTC outcomesPremature attritionDisorder diagnosisEarly assessmentTC treatmentDisordersTreatmentTherapeutic communityOutcomes
2010
Cost evaluation of evidence-based treatments.
Sindelar JL, Ball SA. Cost evaluation of evidence-based treatments. Addiction Science & Clinical Practice 2010, 5: 44-51. PMID: 22002453, PMCID: PMC3120119.Peer-Reviewed Original ResearchInformal discussions in substance abuse treatment sessions with Spanish-speaking clients
Bamatter W, Carroll KM, Añez LM, Paris M, Ball SA, Nich C, Frankforter TL, Suarez-Morales L, Szapocznik J, Martino S. Informal discussions in substance abuse treatment sessions with Spanish-speaking clients. Journal Of Substance Use And Addiction Treatment 2010, 39: 353-363. PMID: 20817381, PMCID: PMC2967664, DOI: 10.1016/j.jsat.2010.07.005.Peer-Reviewed Original ResearchConceptsMotivational enhancement therapyStandard treatmentDrug Abuse Clinical Trials Network protocolTreatment sessionsSubstance abuse treatment outcomesSignificant inverse correlationHispanic clientsEarly treatment sessionsSession audiotapesTreatment outcomesSubstance abuse treatment sessionsEnhancement therapyClient motivationSubstance useInverse correlationTreatment fidelityNational InstituteTreatmentAdverse consequencesTrialsSessionsClient retentionMonolingual SpanishTeaching community program clinicians motivational interviewing using expert and train‐the‐trainer strategies
Martino S, Ball SA, Nich C, Canning‐Ball M, Rounsaville BJ, Carroll KM. Teaching community program clinicians motivational interviewing using expert and train‐the‐trainer strategies. Addiction 2010, 106: 428-441. PMID: 20925684, PMCID: PMC3017235, DOI: 10.1111/j.1360-0443.2010.03135.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultClinical CompetenceConnecticutEducation, Medical, ContinuingEducational MeasurementFemaleHumansInterview, PsychologicalMaleMiddle AgedMotivationProgram DevelopmentProgram EvaluationRegression AnalysisSubstance Abuse Treatment CentersSubstance-Related DisordersTeachingTeaching MaterialsTechnology TransferConceptsClinical trial standardsTreatment programPercentage of cliniciansMental health treatment programsCommunity treatment programsMI adherencePrimary outcomeClinician adherenceProgram cliniciansMI performanceTrainer strategyCliniciansAddiction treatmentTrial standardsTrainer approachAdherenceTT conditionsHigh percentageTreatmentSkill-building workshopsTTExMIEffective strategyStudy
2009
A treatment for substance abusing pregnant women
Yonkers KA, Howell HB, Allen AE, Ball SA, Pantalon MV, Rounsaville BJ. A treatment for substance abusing pregnant women. Archives Of Women's Mental Health 2009, 12: 221. PMID: 19350369, PMCID: PMC3103065, DOI: 10.1007/s00737-009-0069-2.Peer-Reviewed Original ResearchConceptsPregnant womenMaternal Health ClinicRoutine prenatal careManualized behavioral treatmentYale AdherencePrenatal careClinical trialsHealth clinicsHealth cliniciansBreath testBehavioral treatmentPilot studySubstance useMotivational interviewingSmall urban cityTreatment fidelityTreatment deliveryWomenTherapyCognitive therapyTreatmentSelf-ReportNew HavenClinicCliniciansSubstance User Treatment Dropout from Client and Clinician Perspectives: A Pilot Study
Palmer RS, Murphy MK, Piselli A, Ball SA. Substance User Treatment Dropout from Client and Clinician Perspectives: A Pilot Study. Substance Use & Misuse 2009, 44: 1021-1038. PMID: 19938942, PMCID: PMC3678276, DOI: 10.1080/10826080802495237.Peer-Reviewed Original ResearchConceptsClinician's perspectiveTreatment dropoutPilot studyClient-level factorsSample of cliniciansEarly therapeutic allianceAfrican AmericansTreatment retentionTreatment attendanceSubstance user treatmentAlcohol useCliniciansTherapeutic allianceUser treatmentHeavy drugSocial supportCaucasiansTreatmentClient motivationPremature terminationProgram characteristicsPrimary reasonAbstinence
2008
Enduring effects of a computer-assisted training program for cognitive behavioral therapy: A 6-month follow-up of CBT4CBT
Carroll KM, Ball SA, Martino S, Nich C, Babuscio TA, Rounsaville BJ. Enduring effects of a computer-assisted training program for cognitive behavioral therapy: A 6-month follow-up of CBT4CBT. Drug And Alcohol Dependence 2008, 100: 178-181. PMID: 19041197, PMCID: PMC2742309, DOI: 10.1016/j.drugalcdep.2008.09.015.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyBehavioral therapyComputer-assisted training programSubstance dependenceComputer-based trainingSubstance use outcomesComputer-assisted versionDrug useEnduring effectCBT4CBTUse outcomesRandomized clinical trialsTreatment retentionDurability of effectTraining programOutpatient communityStudy treatmentStandard treatmentOutpatient treatmentClinical trialsTreatment conditionsParticipantsSignificant differencesTreatmentRegression analysisWhat is usual about “treatment-as-usual”? Data from two multisite effectiveness trials
Santa Ana EJ, Martino S, Ball SA, Nich C, Frankforter TL, Carroll KM. What is usual about “treatment-as-usual”? Data from two multisite effectiveness trials. Journal Of Substance Use And Addiction Treatment 2008, 35: 369-379. PMID: 18337053, PMCID: PMC2712113, DOI: 10.1016/j.jsat.2008.01.003.Peer-Reviewed Original ResearchConceptsEffectiveness trialDrug Abuse Clinical Trials NetworkSubstance useMultisite effectiveness trialClinical Trials NetworkStandard clinical practiceParticipants' substance useCommunity-based drug abuse treatmentDrug abuse treatmentNumber of interventionsSubstance use outcomesPatient outcomesClinical practiceTrials NetworkAbuse treatmentUse outcomesNational InstituteSocial functioningTreatmentTrialsOpen-ended questionsOutcomesStandard practiceEarly stagesEarly sessions
2002
MET meets the real world: design issues and clinical strategies in the Clinical Trials Network
Network F, Carroll K, Farentinos C, Ball S, Crits-Christoph P, Libby B, Morgenstern J, Obert J, Polcin D, Woody G. MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. Journal Of Substance Use And Addiction Treatment 2002, 23: 73-80. PMID: 12220604, PMCID: PMC3651591, DOI: 10.1016/s0740-5472(02)00255-6.Peer-Reviewed Original ResearchConceptsClinical Trials NetworkBrief behavioral treatmentMotivational enhancement therapyDrug abuse treatment programsSubstance abuse treatmentCommunity-based drug abuse treatment programsEnhancement therapyTraining of cliniciansBehavioral treatmentMotivational interviewingTrials NetworkAbuse treatmentCommunity programsTreatment programStudy treatmentRange of studiesClinical trialsClinical strategiesReal worldTrainingStudy sampleTreatmentInterviewingProgramPharmacologic
2001
Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement
Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ. Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement. JAMA Psychiatry 2001, 58: 755-761. PMID: 11483141, PMCID: PMC3651594, DOI: 10.1001/archpsyc.58.8.755.Peer-Reviewed Original ResearchConceptsDrug-free urine specimensNaltrexone treatmentFamily counseling sessionsContingency managementOpioid dependenceTreatment retentionUrine specimensBehavioral therapyOpioid-dependent individualsCounseling sessionsDrug use outcomesSubstance abuse outcomesNaltrexone complianceNaltrexone therapyOpioid useAvailable pharmacotherapiesMedication complianceSpecific pharmacotherapySignificant improvementTherapyUse outcomesAbuse outcomesPrincipal outcomePharmacotherapyTreatment
2000
Comorbid Psychopathology in Binge Eating Disorder: Relation to Eating Disorder Severity at Baseline and Following Treatment
Wilfley D, Friedman M, Dounchis J, Stein R, Welch R, Ball S. Comorbid Psychopathology in Binge Eating Disorder: Relation to Eating Disorder Severity at Baseline and Following Treatment. Journal Of Consulting And Clinical Psychology 2000, 68: 641-649. PMID: 10965639, DOI: 10.1037/0022-006x.68.4.641.Peer-Reviewed Original ResearchConceptsAxis II psychopathologyComorbid psychopathologyDisorder severityStructured Clinical InterviewCluster B personality disordersAxis I psychopathologyBinge Eating DisorderB personality disordersEating Disorder ExaminationTreatment outcomesPsychotherapy trialsCluster B disordersBED patientsClinical InterviewDSM-IIISevere bingeDisorder ExaminationDisorder psychopathologyPersonality disorderEating DisordersBingeDisordersBaselineB disordersTreatmentMultidimensional subtypes and treatment outcome in first-time dwi offenders
Ball S, Jaffe A, Crouse-Artus M, Rounsaville B, O'Malley S. Multidimensional subtypes and treatment outcome in first-time dwi offenders. Addictive Behaviors 2000, 25: 167-181. PMID: 10795943, DOI: 10.1016/s0306-4603(99)00053-2.Peer-Reviewed Original ResearchConceptsPatient-treatment matching effectsPremorbid risk factorsType A/BFirst-time DWI offendersRisk factorsTreatment outcomesSevere symptomsBaseline assessmentPsychosocial severitySevere typeAlcoholism subtypesTreatment matchingType BAlcoholism researchGroup treatmentHigher stageType ASubtypesPredictive validityDrinking consequencesTreatmentType BsDWI offendersSymptomsTwo-cluster solutionA general system for evaluating therapist adherence and competence in psychotherapy research in the addictions
Carroll K, Nich C, Sifry R, Nuro K, Frankforter T, Ball S, Fenton L, Rounsaville B. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug And Alcohol Dependence 2000, 57: 225-238. PMID: 10661673, DOI: 10.1016/s0376-8716(99)00049-6.Peer-Reviewed Original ResearchConceptsTherapist adherenceRandomized clinical trialsSubstance use disordersDrug abuse treatmentYale AdherenceClinical trialsPharmacotherapy researchUse disordersBehavioral treatmentAbuse treatmentClinical researchAdherenceTreatmentComparison treatmentCompetence scoresExcellent reliabilityAddictionDiscriminant validityCompetence ScaleFactor structurePsychotherapy research